769 related articles for article (PubMed ID: 8801766)
1. Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis.
Eriksson L; Kristensen J; Olsson K; Bring J; Högman CF
Vox Sang; 1996; 70(2):69-75. PubMed ID: 8801766
[TBL] [Abstract][Full Text] [Related]
2. In-vivo evaluation of random donor platelet concentrates from pooled buffy coats.
Klüter H; Dörges L; Maass E; Wagner T; Bartels H; Kirchner H
Ann Hematol; 1996 Aug; 73(2):85-9. PubMed ID: 8774617
[TBL] [Abstract][Full Text] [Related]
3. Functional capacity of transfused platelets estimated by the Thrombostat 4000/2.
Kristensen J; Eriksson L; Olsson K; Killander A; Högman C
Eur J Haematol; 1993 Sep; 51(3):152-5. PubMed ID: 8405329
[TBL] [Abstract][Full Text] [Related]
4. Platelet concentrates in an additive solution prepared from pooled buffy coats. In vivo studies.
Eriksson L; Shanwell A; Gulliksson H; Högman CF; Svensson LA; Kristensen J; Berg B
Vox Sang; 1993; 64(3):133-8. PubMed ID: 8484245
[TBL] [Abstract][Full Text] [Related]
5. Determination
Thuku NW; Shikuku K; Mbugua A
Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
[TBL] [Abstract][Full Text] [Related]
6. Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy.
Akkök CA; Brinch L; Lauritzsen GF; Solheim BG; Kjeldsen-Kragh J
Vox Sang; 2007 Jul; 93(1):42-8. PubMed ID: 17547564
[TBL] [Abstract][Full Text] [Related]
7. Clinical and laboratory experience with erythrocyte and platelet preparations from a 0.5CPD Erythro-Sol opti system.
Högman CF; Eriksson L; Wallvik J; Payrat JM
Vox Sang; 1997; 73(4):212-9. PubMed ID: 9407638
[TBL] [Abstract][Full Text] [Related]
8. Storage-induced change in platelet transfusion response evaluated by serial transfusions from one donor to one patient.
Tynngård N; Boknäs N; Trinks M; Dreimane A; Berlin G
Transfusion; 2019 Feb; 59(2):723-728. PubMed ID: 30548486
[TBL] [Abstract][Full Text] [Related]
9. Transfusion of platelet concentrates--clinical evaluation of two preparations.
Strindberg J; Berlin G
Eur J Haematol; 1996 Oct; 57(4):307-11. PubMed ID: 8982294
[TBL] [Abstract][Full Text] [Related]
10. WBC-reduced platelet concentrates from pooled buffy coats in additive solution: an evaluation of in vitro and in vivo measures.
van der Meer PF; Pietersz RN; Tiekstra MJ; Huijgens PC; Dekker WJ; Reesink HW
Transfusion; 2001 Jul; 41(7):917-22. PubMed ID: 11452160
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium.
Bertolini F; Rebulla P; Riccardi D; Cortellaro M; Ranzi ML; Sirchia G
Transfusion; 1989 Sep; 29(7):605-9. PubMed ID: 2773027
[TBL] [Abstract][Full Text] [Related]
12. Leukocyte-depleted platelets prepared from pooled buffy coat post-transfusion increment and "in vitro bleeding time" using the Thrombostat 4000/2.
Högman CF; Eriksson L; Kristensen J
Transfus Sci; 1993 Jan; 14(1):35-9. PubMed ID: 10148311
[TBL] [Abstract][Full Text] [Related]
13. Comparative assessment of prophylactic transfusions of platelet concentrates obtained by the PRP or buffy-coat methods, in patients undergoing allogeneic hematopoietic stem cell transplantation.
Fernández-Muñoz H; Plaza EM; Rivera-Caravaca JM; Candela MJ; Romera M; De Arriba F; Lozano ML; Vicente V; Heras I; Castilla-Llorente C; Rivera J
Hematology; 2018 Oct; 23(9):712-718. PubMed ID: 29582705
[TBL] [Abstract][Full Text] [Related]
14. Preparation of leucocyte-poor platelet concentrates from buffy coats. IV. Clinical evaluation.
Pietersz RN; Reesink HW; Huijgens PC; van Oers MH
Vox Sang; 1988; 55(3):129-32. PubMed ID: 3070936
[TBL] [Abstract][Full Text] [Related]
15. Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomized study.
de Wildt-Eggen J; Nauta S; Schrijver JG; van Marwijk Kooy M; Bins M; van Prooijen HC
Transfusion; 2000 Apr; 40(4):398-403. PubMed ID: 10773049
[TBL] [Abstract][Full Text] [Related]
16. Incubation of platelet concentrates before transfusion does not improve posttransfusion recovery.
Hussein MA; Schiffer CA; Lee EJ
Transfusion; 1990 Oct; 30(8):701-3. PubMed ID: 2219256
[TBL] [Abstract][Full Text] [Related]
17. Implementation of a new platelet pooling system for platelet concentrates led to a higher corrected count increment after transfusion: a comparative observational study of platelet concentrates before and after implementation.
Dijkstra-Tiekstra MJ; van de Watering LM; Rondeel JM; Slomp J; de Wildt-Eggen J
Transfus Med; 2014 Apr; 24(2):99-104. PubMed ID: 24506143
[TBL] [Abstract][Full Text] [Related]
18. Comparison of posttransfusion recoveries achieved with either fresh or stored platelet concentrates.
Peter-Salonen K; Bucher U; Nydegger UE
Blut; 1987 Apr; 54(4):207-12. PubMed ID: 3828538
[TBL] [Abstract][Full Text] [Related]
19. A randomized study of buffy coat platelets in platelet additive solution stored 1-5 versus 6-7 days prior to prophylactic transfusion of allogeneic haematopoietic progenitor cell transplant recipients.
Diedrich B; Ringdén O; Watz E; Shanwell A
Vox Sang; 2009 Oct; 97(3):254-9. PubMed ID: 19508669
[TBL] [Abstract][Full Text] [Related]
20. Quality control of platelet concentrates by the Thrombostat 4000.
Böck M; Groh J; Glaser A; Storck K; Kratzer MA; Heim MU
Semin Thromb Hemost; 1995; 21 Suppl 2():91-5. PubMed ID: 7660164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
